| Key Figures. |
|
|
|
|
|
|
| |
|
2004/20051) |
|
2003/20042) |
|
Change |
| Statement of Income (€ million)3) |
|
|
|
|
|
|
| Net sales |
|
1,744 |
|
1,576 |
|
11 % |
| Gross profit |
|
486 |
|
458 |
|
6 % |
| Gross profit as a percentage of net sales |
|
28 % |
|
29 % |
|
– |
| Research & development expenses |
|
–78 |
|
–73 |
|
7 % |
| R&D expenses as a percentage of net sales |
|
4 % |
|
5 % |
|
– |
| Selling, general and administration expenses4) |
|
–271 |
|
–272 |
|
0 % |
| SG&A expenses as a percentage of net sales |
|
16 % |
|
17 % |
|
– |
| Operating profit (EBIT) |
|
137 |
|
113 |
|
21 % |
| Goodwill amortization |
|
0 |
|
3 |
|
– |
| EBITA5) |
|
137 |
|
116 |
|
17 % |
| EBITA as a percentage of net sales |
|
7.9 % |
|
7.4 % |
|
– |
Depreciation of tangible assets and amortization
of licenses |
|
31 |
|
27 |
|
15 % |
| EBITDA |
|
168 |
|
143 |
|
17 % |
| EBITDA as a percentage of net sales |
|
9.6 % |
|
9.1 % |
|
– |
| Net profit for the period |
|
55 |
|
44 |
|
25 % |
| Net profit for the period as a percentage of net sales |
|
3.2 % |
|
2.8 % |
|
– |
| Net profit for the period before carve-out |
|
71 |
|
61 |
|
16 % |
| Earnings per share (€)6) |
|
4.29 |
|
3.68 |
|
– |
| |
|
|
|
|
|
|
| Cash flow (€ million) |
|
|
|
|
|
|
| Cash flow from operating activities |
|
133 |
|
122 |
|
9 % |
| Cash flow from investment activities |
|
–55 |
|
–49 |
|
12 % |
| |
|
|
|
|
|
|
| |
|
Sept. 30, 2005 |
|
Sept. 30, 2004 |
|
Change |
| Key Balance Sheet Figures (€ million) |
|
|
|
|
|
|
| Working Capital |
|
204 |
|
183 |
|
21 |
| as a percentage of net sales (annualized) |
|
12 % |
|
12 % |
|
– |
| Net debt |
|
176 |
|
234 |
|
–58 |
| Equity |
|
228 |
|
194 |
|
34 |
| |
|
|
|
|
|
|
| Human Resources |
|
|
|
|
|
|
| Number of employees (September, 30) |
|
6,937 |
|
6,114 |
|
823 |
